Muscle loss (atrophy) due to inactivity is common after illness, injury, hospitalization or falls, and becomes increasingly ...
Please provide your email address to receive an email when new articles are posted on . An investigational, fully human monoclonal antibody developed as a muscle-targeted therapy for spinal muscular ...
HOUSTON – A newly identified gene, atrogin-1, is involved in muscle loss associated with cancer, diabetes, fasting and kidney disease as well as in the atrophy occurring with disuse, inactivity, and ...
Panelists discuss how the current spinal muscular atrophy (SMA) treatment landscape includes 3 options: gene therapy (onasemnogene abeparvovec [Zolgensma]) for younger patients and 2 splice modifiers ...
A Prescription Drug User Fee Act target date of September 22, 2025 has been set for the application. The Food and Drug Administration (FDA) has accepted for Priority Review the Biologics License ...
Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. So most recently, there has been the ...
This is six year old Emma Nowll and like so many kids her age. She is *** prankster. You can also call her. She hates it when I try to help her so um the best thing I can do for her is to just teach ...
Vijayawada: Marking World Rare Disease Day, the Amaravati Rare Diseases Organisation (ARDO) organised the “3K Run for Rare–2026” awareness programme on Friday at BRTS Road near Sarada College ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results